New CEO appointed to ANSTO
The Chair of the Australian Nuclear Science and Technology Organisation (ANSTO), the Hon Dr Annabelle Bennett AC SC, has announced that Shaun Jenkinson has been appointed Chief Executive Officer of ANSTO following a global search to fill the position.
Dr Bennett said that the global search identified a number of exceptional candidates and that Jenkinson was chosen following a rigorous selection process. He has been serving as Acting CEO of ANSTO since September 2020 but has now been officially appointed for a three-year term effective 31 March 2021.
“Shaun has the right mix of skills and experience, as well as the values, to ensure that ANSTO is able to continue to deliver on its key mandates, which are so important to Australia as we recover and grow post COVID-19,” Dr Bennett said.
Jenkinson has over 30 years’ experience across the pharmaceuticals, medical equipment and medical devices industries. He joined ANSTO in March 2010, working with the team in ANSTO Health to ensure an ongoing supply of radioisotopes to the domestic market as well as delivering export sales growth. As Group Executive Nuclear Business, his responsibilities covered all commercial operations including ANSTO Health, ANSTO Minerals, ANSTO Silicon, Mo-99 Operations, ANSTO Radiation Services, Business Development and international business partnerships.
Prior to joining ANSTO, he held senior leadership positions with large global companies, both in the UK and Australia, delivering top- and bottom-line growth across a range of products in different market segments. He has a degree in biotechnology and is a graduate of the Australian Institute of Company Directors.
“This is an important time for ANSTO, to ensure continued sustainability and delivery of nuclear medicines and other products and services that make major contributions to the Australian community,” Dr Bennett said. “Shaun is the right person to guide ANSTO at this time.”
“It is a huge privilege and a great responsibility to take on this role,” Jenkinson said. “I will commit to it with everything I have to create an environment where both the individual and the combined efforts of the talented people at ANSTO are recognised and can flourish.
“ANSTO holds an important position in the research and scientific landscape. The role we play contributes to the current and future health, wellbeing, knowledge and economic success of Australia.
“The last 12 months have been played out against the background of a global pandemic, and ANSTO responded well to that challenge.
“We now recognise we are operating in a significantly different environment — an environment that will require science and engineering and important organisations like ANSTO to continue to deliver solutions to the challenges Australia faces.
“We have a refreshed organisational strategy, and the plans to deliver on that strategy are being rolled out.
“Our success will be determined by our ability to implement these plans. It is essential that we measure our progress and constantly challenge our performance so that we can adjust our plans as required.
“I look forward to working with everyone as we progress towards our goals.”
CytoCell University aims to partner with scientists to provide innovative and expert training on...
BioAgilytix Labs describes 360biolabs as the most comprehensive contract research organisation in...
The Office for Women is providing $39.8 million over three years to 60 organisations as part of...